Cancer patients often have compromised immune systems due to the disease itself or the treatments they undergo, such as chemotherapy and radiation therapy. This immunocompromised state makes them more susceptible to infections, including those caused by pneumococcal bacteria. Given their increased risk, receiving the PPSV23 vaccine can significantly lower the chances of developing severe pneumococcal diseases, which can be life-threatening for cancer patients.